1. Market Research
  2. > Pathology Industry

lymphoma Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, In Vitro Instrument, Flow Cytometry, Pap Smear, Oncology, Therapeutics, Antibody, Cancer Diagnostic, Clinical Trial, Computed Tomography, Nuclear Medicine, Pharmaceutical, Blood Supply, Nuclear Imaging, Rituximab, Therapy.


 
1-10 of about 100 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Global Lymphoma Partnering 2010 to 2016

Global Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Lymphoma Treatment Drugs Markets in China

Lymphoma Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • May 2016
  • by Asia Market Information & Development Company

China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

Lymphoma Treatment Drugs Companies in China

Lymphoma Treatment Drugs Companies in China

  • $ 1 800
  • Industry report
  • May 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Lymphoma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the ...

Lymphoma Treatment Drugs Industry Forecasts - China Focus

Lymphoma Treatment Drugs Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • May 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Lymphoma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral ...

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary The Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare company that offers blood cancer researches and funds raising services. The company’s services include patient services, health education, ...

Indolent Lymphoma - Pipeline Review, H1 2016

Indolent Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Indolent Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape. The ...

Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. ...

Hodgkin Lymphoma - Pipeline Review, H1 2016

Hodgkin Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report ...

About 3 000 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • October 2015
    201 pages
  • Cancer  

    Rituximab  

    Cancer Drug  

  • Canada  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.